Providers

Fatigue Broadly Impacts Patients With RA, Psoriatic Arthritis, Axial Spondyloarthritis

August 08, 2020

Article

A new study in PLOS ONE has highlighted the broad impact fatigue can have on patients with rheumatoid arthritis (RA), psoriatic arthritis, and axial spondyloarthritis.

Reorganization of Sickle Cell Care Leads to Dramatic Drop in Hospitalizations

August 07, 2020

Article

Yale New Haven Hospital’s reorganization of its sickle cell disease program led patients to report feeling better off and needing fewer hospitalizations. However, the change left some with the disease still feeling unsatisfied.

JUMP Provides Additional Safety, Efficacy Data on Ruxolitinib in Myelofibrosis

August 07, 2020

Article

In the primary analysis of a phase 3 study, ruxolitinib reduced spleen length and symptoms in patients with myelofibrosis, according to results published in British Journal of Haemotology.

Patients With IPF Are at Increased Risk for Multiple Cancers

August 06, 2020

Article

Researchers found that patients with idiopathic pulmonary fibrosis (IPF) are at increased risk of developing several forms of cancer compared with the general population.

Real-World Analysis: Secukinumab Improves Psoriatic Arthritis Outcomes at 6 Months

August 06, 2020

Article

Just like in clinical trials, a real-world analysis of patients with psoriatic arthritis who were treated with secukinumab achieved minimal disease activity, as well as other improvements.

Hospital-Acquired Pneumonia Possibly Linked to Worse Outcomes Among Patients With Acute Heart Failure

August 06, 2020

Article

Prevention and early screening efforts need to be stepped up for patients with acute heart failure who contract pneumonia while hospitalized.

Can a Community-Based Care Management Program Reduce Costs, Visits Among Medicaid Enrollees?

August 06, 2020

Podcast

Krisda H. Chaiyachati, MD, MPH, MSHP, discusses the study he co-wrote entitled “Economic Outcomes of Insurer-Led Care Management for High-Cost Medicaid Patients.”

Novartis Says Tisagenlecleucel Met CRR in Early FL Data

August 05, 2020

Article

Tisagenlecleucel, sold as Kymriah by Novartis, met its primary end point of complete response rate (CRR) in an interim analysis of a phase 2 study for relapsed or refractory follicular lymphoma (FL).

Cancer Care in the Age of COVID-19: Dr Patricia Salber Interviews Dr Bobby Reddy

August 05, 2020

Podcast

Patricia Salber, MD, MBA, of The Doctor Weighs In, and Sandeep “Bobby” Reddy, MD, an oncologist at Harbor-UCLA Medical Center and chief medical officer of NantHealth, discuss the clinical care of patients with cancer in the age of COVID-19.

Experts Highlight COVID-19 Vaccine Developments and Remaining Challenges

August 04, 2020

Article

The coronavirus disease 2019 (COVID-19) vaccines that are leading the pack are utilizing a new vaccine technology that has never been approved for human use by the FDA. As a result, there are a lot of unknowns.